Bioengineering market in China luring Korean investors

Published: 2002-09-09 06:58:00

Updated: 2002-09-09 06:58:00

Business sources say that the bio-industry collaboration between China and Korea in the government level will be accelerated amid the growing interests of the domestic pharmaceutical firms and biodrug companies in the Chinese bioengineering market, since China's affiliation with the WTO.

The domestic large businesses, such as SK, Jeil Chedang, LGCI, Chong Kun Dang, Daesang, Kumho Petroleum C...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.